BOTOX Treatment in Pediatric Upper Limb Spasticity: Double-blind Study

Trial Profile

BOTOX Treatment in Pediatric Upper Limb Spasticity: Double-blind Study

Recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Aug 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Muscle spasticity
  • Focus Registrational; Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 05 Aug 2017 This trial has been completed in Hungary (end date: 6 Jul 2017).
    • 31 Jul 2017 This trial has been completed in Germany (end date: 2017-07-06)
    • 12 Sep 2016 Planned number of patients changed from 412 to 224.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top